Zelira Therapeutics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.054723 million compared to AUD 0.076949 million a year ago. Net loss was AUD 34.13 million compared to AUD 3.28 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 AUD | -3.60% | -1.47% | -25.56% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.56% | 5.02M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023